NCT06147063 A Randomized Trial Evaluating a mRNA-VLP Vaccine's Immunogenicity and Safety for COVID-19 Status COMPLETED Phase PHASE1
NCT06113744 A Phase 1 Study to Evaluate the Safety and Immunogenicity of COVID-19 Vaccine Status RECRUITING Phase PHASE1
NCT06113731 A PhaseⅡ Study to Evaluate the Safety and Immunogenicity of COVID-19 Vaccine Status RECRUITING Phase PHASE2
NCT06099795 Evaluation of Concordance Between Exhaled Air Test (eBAM-CoV) and RT-PCR to Detect SARS-CoV-2 Status RECRUITING Phase NA
NCT06026514 Phase I Safety Study of B/HPIV3/S-6P Vaccine Via Nasal Spray in Adults Status COMPLETED Phase PHASE1
NCT05997290 A Study to Learn About New COVD-19 RNA Vaccine Candidates for New Variants in Healthy Individuals Status COMPLETED Phase PHASE2/PHASE3
NCT05952505 Immunogenicity and Safety of an Inactivated SARS-CoV-2 Vaccine Coadministered With Two Attenuated Vaccines Status UNKNOWN Phase PHASE4
NCT05933512 A Study to Evaluate the Immunogenicity and Safety of A Recombinant Protein COVID-19 Vaccine as Booster Vaccines Status UNKNOWN Phase PHASE2
NCT05911906 An Open-label, Clinical Feasibility Study of the Efficacy of Remdesivir for Long-COVID. Status COMPLETED Phase PHASE4
NCT05897541 Phase 3 Study of S-217622 in Prevention of Symptomatic SARS-CoV-2 Infection Status COMPLETED Phase PHASE3
NCT05892549 COVID-19: Early Detection of Worsening by Voice and Respiratory Pattern Characteristics Status RECRUITING Phase N/A
NCT05844202 Safety, Tolerability and Immunogenicity of Alveavax-v1.2, a BA.2/Omicron-optimized, DNA Vaccine for COVID-19 Prevention Status COMPLETED Phase PHASE1
NCT05799495 A Study to Understand the Effect and Safety of the Study Medicine PF-07817883 in Adults Who Have Symptoms of COVID-19 But Are Not Hospitalized Status COMPLETED Phase PHASE2
NCT05794412 Mucosal Immunity: Influence on Infectious Viral Load: a Prospective Observational Study Status COMPLETED Phase N/A
NCT05778383 Zinc Supplementation Impact in Acute COVID-19 Clinical Outcomes Status COMPLETED Phase PHASE4
NCT05769803 Viral Load Analysis of the SARS-CoV-2 Virus in Nose Versus Mouth Sites Status UNKNOWN Phase NA
NCT05765279 A Study to Assess the Efficacy of HH-120 Nasal Spray for Prevention of SARS-CoV-2 Infection in Adult Close Contacts of Individuals Infected With SARS-CoV-2 Status COMPLETED Phase NA
NCT05747677 A Study of HH-120 Nasal Spray in Close Contacts of Those Diagnosed With COVID-19 Status COMPLETED Phase NA